Biotech Unveiled
Why is it so hard to develop a new drug for patients?
Take this free course to learn what it really takes — from risk and regulation to failure and persistence — for innovators and investors to turn scientific ideas into breakthrough medicines.
Hear directly from the investors driving America’s biotech engine.
About the Course
Biotech Unveiled offers 8 chapters that span all aspects of the biotech ecosystem.
Topics include:
The Drug Development Process
The Venture Capital Perspective
Market-Based Pharmaceutical Pricing
Why Brands Must Go Generic
The Role of Insurance
And much more. Altogether, the course takes 6-10 hours to complete.
Upon completion, you will receive a Biotech Unveiled completion certificate for display on your LinkedIn and other social media. This authenticated certificate shows peers and recruiters your command of key innovation fundamentals. Plus, it qualifies you to apply for the NPLB Biotech Fellowship, where you’ll unlock access to a wider range of speakers, our engaged fellowship network, and more.
Biotech Unveiled is designed and run by our partner, RA Capital.
The American biotech ecosystem is fragile, and policy changes can have a significant impact on the number and kinds of drugs the U.S. will discover over the next decade. Learn how drug innovation really works, so you can better shape the future of medicine.
Whether you’re a student, academic, policymaker, or just curious about how lifesaving drugs are made, this course is for you.
We all have an interest in getting this right. Our lives may one day depend on it.
Already completed the course?
Apply for the NPLB Biotech Fellowship
Learn from an even larger group of experts from all over the biotech ecosystem.
Join the fellowship to:
Participate in live lessons on health economics, policy and investing
Connect with like-minded fellows and industry leaders in biotech
Collaborate on impactful projects with real-world value
